Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 21.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 6,400 shares, a drop of 21.0% from the December 31st total of 8,100 shares. Based on an average trading volume of 5,500 shares, the days-to-cover ratio is presently 1.2 days.

Lexaria Bioscience Stock Performance

Shares of LEXXW traded down $0.06 during mid-day trading on Friday, hitting $0.38. The stock had a trading volume of 3,172 shares, compared to its average volume of 8,534. The business has a fifty day moving average price of $0.68 and a 200-day moving average price of $0.89. Lexaria Bioscience has a 52 week low of $0.38 and a 52 week high of $2.50.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.